CBL and gastric cancer: To further identify the effect of DR5‐Cbl‐b/c‐Cbl‐TRAF2 complex on TRAIL sensitivity, we examined the expression of these proteins in TRAIL‐resistant (BGC823 and MGC803) and TRAIL‐sensitive (HGC27 and MKN45) gastric cancer cells (Fig. 8A).